India link in fresh US insider trading scam
- CBI sought part RTI exemption, Govt gave it full
- Screen Awards: Milkha, Ram-Leela and Madras Cafe dominate
- DGCA seeks fresh public objections after clearing AirAsia for take-off
- Delhi: 51-year-old Danish national alleges gangrape, 15 detained for questioning
- I wonder if I will be able to ever reunite with my husband, my kids. I miss them: Devyani
A prominent Indian-origin hedge fund portfolio manager has been charged with participating in one of the "most lucrative" insider trading schemes ever in the US.
Mathew Martoma, 38, has been charged with using material, non-public information that he received from a doctor on the clinical trial of an Alzheimer's drug to make profits and avoid losses for his hedge fund for an amount totalling approximately $276 million.
Martoma, who was arrested last week from his home in Boca Raton, Florida, was released on Monday on a $5 million bail after a brief hearing at the Manhattan federal court here. He did not enter any plea and the judge set the next hearing for December 26.
The US Securities and Exchange Commission has also filed a civil insider trading case against him.
- AAP names Bharti victims, uploads eight videos targeting Africans in Delhi
- Kapil Sibal to contest from Chandni Chowk in 2014, even if Arvind Kejriwal inÂ fray
- Arvind Kejriwal likely to pass Jan Lokpal Bill in February, says the fight for new independence hasÂ begun
- Movie review: â€˜Jai hoâ€™ | The Indian Express